Exploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of Refractory Autoimmune Diseases

Clinical trial NCT06316791 · RECRUITING

Trial details

NCT number: NCT06316791
Sponsor: Juventas Cell Therapy Ltd.
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Lupus Erythematosus, Systemic

Start date: 2021-12-14
Primary completion: 2025-12-13
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.